Formulation & evaluation of aripiprazole solid lipid nanoparticles for brain targeting

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2014, Vol 2, Issue 5

Abstract

The objective of this research work was to formulate Aripiprazole solid lipid nanoparticles for brain targeting by surpassing the Blood brain barrier (BBB) and increasing the retention time in the brain for better therapy. The peaks obtained in the physical mixture were mostly identical with the peaks of the pure sample indicating their compatibility. The Solid lipid nanoparticles containing Aripiprazole was formulated by High speed homogenization technique using Ultra Turrax T25, IKA high speed homogenizer. When subjected to evaluation, it was observed that maximum entrapment efficiency was achieved with formulations F8 and F11. In-vitro diffusion studies of all the formulations followed firstorder kinetics and ascertained Peppas mechanism. Based on the release profile and the entrapment efficiency, the formulations F8 & F11 were found to be the optimized .SEM analysis revealed that the particles were spherical in shape. The particle size range of the solid lipid nanoparticle formulations F8 and F11 were found to be 120nm to 400nm and 150nm to 520nm with the average particle size of 202.6nm and 263.9nm respectively. The zeta potential of the optimized formulations (F8 and F11) were found to be - 28.9 mV & -33.1mV indicating the higher negative surface charge claiming to possess good stability. From the above results, it can be concluded that Aripiprazole Solid lipid nanoparticles could act as better formulation for the effective management of psychotic disorders.

Authors and Affiliations

Sabbavarapu Mary Samyuktha, Nuditelli Mounica, Ravipati Sireesha, Karanki Pavani, Kishore Babu M

Keywords

Related Articles

Spectrophotometric Determination of Capacetabine via their Metal Chelate

A simple, sensitive and accurate spectrophotometric method was described for the estimation of Capacetabine(CPB) a prodrug used as a chemotherapeutic agent used to treat of cancer either in pure form or in the tablet.T...

Preclinical evaluation of cardio protective activity of Grewia hirsuta on doxorubicin induced cardiotoxicity in rats

In this study, an attempt was made to investigate preclinical evaluation of cardio protective activity of Grewiahirsuta induced cardio toxicity in rats. The phytochemical screening was done for the selected plant. The...

Knowledge, perceptions and awareness about HIV/Aids among private university students in Bangladesh

The purpose of the study was to determine the knowledge level of undergraduate students of private university in Bangladesh about HIV/AIDS, their perception of risk of contracting HIV/AIDS based on sexual behavior and...

The curious case of prion proteins:Are they a friend or foe? A review & perspective

Transmissible spongiform encephalopathies (TSE) in humans were known to be caused by prion proteins (PrPC). Recent research has although revealed that prions are an enigmatic protein & their identity holds much more th...

A NOVEL RP- HPLC METHOD DEVELOPMENT AND VALIDATION OF ATORVASTATIN AND FENOFIBRATE IN BULK AND PHARMACEUTICAL DOSAGE FORMS

A fast, robust and accurate RP-HPLC method was developed and validated for simultaneous determination of Losartan potassium and Amlodipine in tablets. The mobile phase was mixture of aqueous Tri ethyl amine with pH 2.0...

Download PDF file
  • EP ID EP33248
  • DOI -
  • Views 294
  • Downloads 0

How To Cite

Sabbavarapu Mary Samyuktha, Nuditelli Mounica, Ravipati Sireesha, Karanki Pavani, Kishore Babu M (2014). Formulation & evaluation of aripiprazole solid lipid nanoparticles for brain targeting. Indian Journal of Research in Pharmacy and Biotechnology, 2(5), -. https://www.europub.co.uk/articles/-A-33248